Clinical Trial Update: Novel Biomarkers and Skeletal Outcomes Associated With Subclinical Thyroid Dysfunction [Phase 4]

View source ↗

Summary

Phase 4 trial assessing novel biomarkers and skeletal outcomes in subclinical thyroid dysfunction, focusing on bone mineral density, osteoporosis, and bone frac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Fracture
• Osteoporosis
• Subclinical Thyroid Dysfunction

Snippet

Sponsor: Insel Gruppe AG, University Hospital Bern | Conditions: Thyroid Dysfunction, Bone Mineral Density | Phase 4 | Status: COMPLETED